Dan Ross

COVID-19 research at the Sanger Institute

We are committed to tracking, understanding and combatting COVID-19. Our staff sequence thousands of virus genomes and use the data to trace transmission, inform public health measures and monitor for new variants of the virus. We also work to understand how the virus interacts with our cells, and to develop new diagnostics

Available to watch now - Functional genomic approaches to guide cancer drug discovery

Dr Garnett is a Group Leader at the Wellcome Sanger Institute in the Cancer, Ageing and Somatic Mutation programme. He and his team investigate how genetic alterations contribute to cancer and impact on patient responses to anti-cancer medicines.

Connect with us on Twitter

As a sequencing hub for the national @CovidGenomicsUK effort, we’re often asked how many #SARSCoV2 genomes we sequence.

These are the numbers, as of this week 🧬⤵️

Check out our blog for more info on the data ➡️ https://sangerinstitute.blog/2021/02/05/sequencing-covid-our-latest-stats/

Image for the Tweet beginning: As a sequencing hub for

We’re delighted to announce an exciting new #PhD opportunity exploring race & ethnicity for #genomic science

Developed by @sangerinstitute & @connectingsci, this is a unique role for a #BAME researcher to develop their career

⏰D/L 04 APR: http://bit.ly/JointPhD #BAMEinSTEM

Image for the Tweet beginning: We’re delighted to announce an